Weight loss
Every weight loss claim we've checked against the studies, newest first, each graded from Solid to Debunked by the evidence in people.

Peptides for weight loss: three approved ones cut 8% to 21%
Wegovy, Zepbound and Saxenda cut body weight 8% to 21% in large randomized trials. Retatrutide and research-only vials are not approved.

Berberine lowers blood sugar in type 2 diabetes trials
In a trial of 409 people with new type 2 diabetes, berberine cut HbA1c 0.4 points more than placebo in 12 weeks. In people without diabetes it did little.

AOD-9604 added under 1 kg of weight loss in a 502-person trial
502 adults took an AOD-9604 tablet or a placebo daily for 24 weeks and lost about the same weight. The injection sold today has never had a human trial.

Foundayo and the Wegovy pill cut weight 11% to 14% in trials
In trials, the daily pills Foundayo (orforglipron) and the Wegovy pill cut weight 11% to 14%. People who switched from a shot to the pill kept most of their loss.

Retatrutide cut body weight by a quarter in its big trial
In a 2,339-person trial, retatrutide's top dose cut weight by 25% on average, or 28% for those who stayed on it. It hasn't been tested head to head with tirzepatide.

For building muscle, 1.6 grams of protein per kilo holds up at every age
Across 49 randomized trials, extra protein added muscle to weight training up to about 1.6 g per kilo a day, and helped people keep muscle while losing weight.

Muscle loss on Ozempic matches any other diet
The claim that 40% of GLP-1 weight loss is muscle mixes up muscle with lean mass. Trial scans show the drugs cost about as much muscle as any weight loss.

